第一作者(含共同)及通讯作者论文(#共同第一作者,*共同通讯作者):
1. Chang H., Cai X., Yang Z.H, Xiao X., Li M*. (2021) Regulation of TRANK1 by GSK-3 in the brain: unexpected interactions. Mol Psychiatry. Online ahead of print. DOI: 10.1038/s41380-021-01120-2.
2. Chang H.#, Cai X.#, Li H.J.#, Liu W.P., Zhao L.J., Zhang C.Y., Wang J.Y., Liu J.W., Ma X.L., Wang L., Yao Y.G., Luo X.J., Li M.*, Xiao X.* (2021) Functional genomics identify a regulatory risk variation rs4420550 in the 16p11.2 schizophrenia-associated locus. Biol Psychiatry 89, 246-255. DOI: 10.1016/j.biopsych.2020.09.016.(封面论文)
3. Chang H.#, Hoshina N.#, Zhang C.#, Ma Y., Cao H., Wang Y., Wu D.D., Bergen S.E., Landen M., Hultman C.M., Preisig M., Kutalik Z., Castelao E., Grigoroiu-Serbanescu M., Forstner A.J., Strohmaier J., Hecker J., Schulze T.G., Muller-Myhsok B., Reif A., Mitchell P.B., Martin N.G., Schofield P.R., Cichon S., Nothen M.M., Swedish Bipolar Study G., Moo D.S.B.C., Walter H., Erk S., Heinz A., Amin N., van Duijn C.M., Meyer-Lindenberg A., Tost H., Xiao X., Yamamoto T.*, Rietschel M.*, Li M.* (2018). The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders. Mol Psychiatry 23, 400-412. DOI: 10.1038/mp.2016.231.(F1000推荐)
4. Chang H.#, Xiao X.#, Li M.* (2017). The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions. Mol Psychiatry 22, 944-953. DOI: 10.1038/mp.2017.19.
5. Cai X.#, Yang Z.H.#, Li H.J., Xiao X., Li M.*, Chang H.* (2021). A Human-Specific Schizophrenia Risk Tandem Repeat Affects Alternative Splicing of a Human-Unique Isoform AS3MTd2d3 and Mushroom Dendritic Spine Density. Schizophr Bull 47, 219-227. DOI: 10.1093/schbul/sbaa098.
6. Li W.#, Cai X.#, Li H.J.#, Song M.#, Zhang C.Y., Yang Y., Zhang L., Zhao L., Liu W., Wang L., Shao M., Zhang Y., Zhang C., Cai J., Zhou D.S., Li X., Hui L., Jia Q.F., Qu N., Zhong B.L., Zhang S.F., Chen J., Xia B., Li Y., Song X., Fan W., Tang W., Tang W., Tang J., Chen X., Yue W., Zhang D., Fang Y., Xiao X., Li M.*, Lv L.*, Chang H.* (2021). Independent replications and integrative analyses confirm TRANK1 as a susceptibility gene for bipolar disorder. Neuropsychopharmacology 46, 1103-1112. DOI: 10.1038/s41386-020-00788-4.
7. Li H.#, Chang H.#, Song X.#, Liu W., Li L., Wang L., Yang Y., Zhang L., Li W., Zhang Y., Zhou D.S., Li X., Zhang C., Fang Y., Sun Y., Dai J.P., Luo X.J., Yao Y.G., Xiao X.*, Lv L.*, Li M.* (2019). Integrative analyses of major histocompatibility complex loci in the genome-wide association studies of major depressive disorder. Neuropsychopharmacology 44, 1552-1561. DOI: 10.1038/s41386-019-0346-3.
8. Zhao L.#, Chang H.#, Zhou D.S.#, Cai J., Fan W., Tang W., Tang W., Li X., Liu W., Liu F., He Y., Bai Y., Sun Y., Dai J., Li L., Xiao X.*, Zhang C.*, Li M.* (2018). Replicated associations of FADS1, MAD1L1, and a rare variant at 10q26.13 with bipolar disorder in Chinese population. Transl Psychiatry 8, 270. DOI: 10.1038/s41398-018-0337-x.
9. Chang H.#, Li L.#, Peng T.#, Grigoroiu-Serbanescu M., Bergen S.E., Landen M., Hultman C.M., Forstner A.J., Strohmaier J., Hecker J., Schulze T.G., Muller-Myhsok B., Reif A., Mitchell P.B., Martin N.G., Cichon S., Nothen M.M., Jamain S., Leboyer M., Bellivier F., Etain B., Kahn J.P., Henry C., Rietschel M., Swedish Bipolar Study G., Moo D.S.C., Xiao X.*, Li M.* (2017). Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1. Mol Neurobiol 54, 5166-5176. DOI: 10.1007/s12035-016-0041-x.
10. Xiao X.#, Luo X.J.#, Chang H.#, Liu Z., Li M.* (2017). Evaluation of European Schizophrenia GWAS Loci in Asian Populations via Comprehensive Meta-Analyses. Mol Neurobiol 54, 4071-4080. DOI: 10.1007/s12035-016-9990-3.
11. Chang H., Li L., Li M.*, Xiao X.* (2017). Rare and common variants at 16p11.2 are associated with schizophrenia. Schizophr Res 184, 105-108. DOI: 10.1016/j.schres.2016.11.031.
12. Li H.#, Zhou D.S.#, Chang H.#, Wang L., Liu W., Dai S.X., Zhang C., Cai J., Liu W., Li X., Fan W., Tang W., Tang W., Liu F., He Y., Bai Y., Hu Z., Xiao X., Gao L.*, Li M.* (2019). Interactome Analyses implicated CAMK2A in the genetic predisposition and pharmacological mechanism of Bipolar Disorder. J Psychiatr Res 115, 165-175. DOI: 10.1016/j.jpsychires.2019.05.024.
13. Chang H.#, Yi B.#, Ma R., Zhang X., Zhao H., Xi Y.* (2016). CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo. Sci Rep 6, 22312. DOI: 10.1038/srep22312.
14. Chang H.#, Li L.#, Peng T., Li M.*, Gao L.*, Xiao X.* (2016). Replication analyses of four chromosomal deletions with schizophrenia via independent large-scale meta-analyses. Am J Med Genet B Neuropsychiatr Genet 171, 1161-1169. DOI: 10.1002/ajmg.b.32502.
15. Chang H.#, Zhang C.*, Xiao X., Pu X., Liu Z., Wu L., Li M.* (2016). Further evidence of VRK2 rs2312147 associated with schizophrenia. World J Biol Psychiatry 17, 457-466. DOI: 10.1080/15622975.2016.1200746.